Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥30 | ¥17 | ¥17 | ¥18 |
| - Cash | ¥2 | ¥3 | ¥4 | ¥4 |
| + Debt | ¥12 | ¥9 | ¥5 | ¥3 |
| Enterprise Value | ¥40 | ¥23 | ¥18 | ¥17 |
| Revenue | ¥51 | ¥47 | ¥45 | ¥43 |
| % Growth | 8% | 4% | 3.8% | – |
| Gross Profit | ¥9 | ¥10 | ¥10 | ¥11 |
| % Margin | 17.1% | 21% | 22.9% | 26.4% |
| EBITDA | ¥7 | ¥8 | ¥9 | ¥10 |
| % Margin | 14.6% | 16.9% | 19.9% | 22.7% |
| Net Income | ¥2 | ¥3 | ¥4 | ¥5 |
| % Margin | 3.8% | 7% | 8% | 10.7% |
| EPS Diluted | 62.72 | 105 | 113.71 | 152.45 |
| % Growth | -40.3% | -7.7% | -25.4% | – |
| Operating Cash Flow | ¥6 | ¥5 | ¥4 | ¥4 |
| Capital Expenditures | -¥7 | -¥6 | -¥6 | -¥5 |
| Free Cash Flow | -¥1 | -¥1 | -¥1 | -¥0 |